Investor's Business Daily July 15, 2026 • 20:16

Why This Biotech Stock, With Its First FDA Approval, Just Crashed By Double Digits - Investor's Business Daily

Why This Biotech Stock, With Its First FDA Approval, Just Crashed By Double Digits - Investor's Business Daily

Celcuity just won FDA approval for its first drug, a treatment for metastatic breast cancer.

Information in Investors Business Daily is for informational and educational purposes only and should not be construed as an offer, recommendation, solicitation, or rating to buy or sell securities. … [+1064 chars]

More from Investor's Business Daily